|
|
 | | | |
- close
- close
- close
- close
Drug Delivery |
Benzinga
Apr 16
Comment
Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of...
Benzinga
Apr 10
Comment
Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Elan Corporation (NYSE: ELN) is 44.98%. Elan's revenue for the same period is $200.00 thousand.
The...
Forbes
Feb 7
Comment
Paints, pigments, coatings, personal care, cosmetics, home care, inkjet media, memory storage, medical devices, drug delivery and biocompatible materials are all made of some type of polymer. So what is the benefit of being able...
Benzinga
Jan 14
Comment
Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.
Hospira (NYSE: HSP) is estimated to post earnings of $0.51 per share in the March quarter. Hospira's trailing-twelve-month...
The Hindu Business Line
Dec 5
Comment
Strides Arcolab Ltd and Eli Lilly have announced a collaboration to expand the delivery of cancer medicines in the emerging markets.As part of this arrangement, Lilly will in-license a portf...
Benzinga
Nov 26
Comment
Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of return on assets.
The trailing-twelve-month return on assets at PetMed Express (NASDAQ: PETS) is 17.56%. PetMed Express' operating margin for the same period is...
New York Times
Nov 24
Comment
Dr. Robert Langer’s lab at the Massachusetts Institute of Technology is on the front lines of turning discoveries into drugs and drug delivery systems.
Reuters
Oct 29
Comment
Contract drugmaker Patheon Inc
will buy Banner Pharmacaps, which focuses on gelatin-based oral
drug delivery technology, for $255 million, to expand its
presence in the...
FierceBiotech
Sep 24
Comment
As head of the Pentagon's $250 million project on regenerative medicine, Dr. Joachim Kohn has pioneered several new technologies: degradable compounds for drug delivery, the use of polymers and tissue scaffolds to create new body parts or rebuild...
FierceBiotech
Sep 18
Comment
Medtronic ($MDT) thinks it has the technology needed to give a drug developer a real edge in the frustrating effort to develop an effective new treatment for Alzheimer's. The medical device company's CNS Drug Delivery chief Lisa Shafer told...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
